Clinical Trial Update: Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the safety of GABITRIL in adults with generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Gabitril (tiagabine)

Snippet

Sponsor: Cephalon | Conditions: General Anxiety Disorder | Phase 3 | Status: COMPLETED